Amneal Pharmaceuticals

PetVivo (NASDAQ: PETV) Stock Quote

Follow Insider Trades Visit website
Last Trade: US$2.07 0.04 1.97
Volume: 4,694
5-Day Change: -0.48%
YTD Change: 5.62%
Market Cap: US$24.200M

Latest News From PetVivo

June 5, 2023
Dr. Thomas Yarbrough Joins PetVivo as the Senior Research Director
MINNEAPOLIS, MN, US, June 05, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Dr. Thomas Yarbrough has accepted a position with the Company as its new Senior Research Director. "Tom is a key addition... Read More
June 1, 2023
Dr. Maureen Dower Joins PetVivo Holdings as a Senior Technical Services Veterinarian
MINNEAPOLIS, MN, US, June 01, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Dr. Maureen Dower has accepted a position with the Company as its new Senior Technical Services Veterinarian. "We are... Read More
May 17, 2023
Trina Lally Joins PetVivo Holdings as the Northeast Business Development Manager
MINNEAPOLIS, MN, US, May 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Trina Lally has accepted a position with the Company as its new Business Development Manager for the Northeast Region of the... Read More
April 27, 2023
Petvivo To Present At Aegis Capital Virtual Conference On May 2-4, 2023
MINNEAPOLIS, April 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today announced it will present a company overview at the Aegis Capital Virtual Conference to be held on May 2nd – 4th, 2023. John Lai, Chief Executive Officer of PetVivo Holdings, Inc., will... Read More
April 25, 2023
Mary Grace Rutland Joins PetVivo Holdings as the Mid-Atlantic Business Development Manager
MINNEAPOLIS, MN, US, April 25, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Mary Grace Rutland has accepted a position with the Company as its new Business Development Manager for the Mid-Atlantic... Read More
April 24, 2023
Petvivo To Exhibit At The ACVSMR Symposium In Charleston, South Carolina
MINNEAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the American College of Veterinary Sports Medicine and Rehabilitation (“ACVSMR”) Symposium to be held April 28th to April 29th 2023 at the Francis Marion Hotel in... Read More
April 14, 2023
Spencer Breithaupt Joins PetVivo Board of Directors
MINNEAPOLIS, MN, US, April 14, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce that Spencer Breithaupt has joined the Company’s Board of Directors. "We are thrilled to welcome Spencer to PetVivo’s Board of Directors”... Read More
March 27, 2023
Petvivo Holdings To Exhibit At The IVAPM Pain Management Forum In Atlanta, Georgia
MINNEAPOLIS, March 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it is a Platinum Sponsor and will be exhibiting at the International Veterinary Academy of Pain Management (“IVAPM”) Pain Management Forum to be held April 2nd to April 4th 2023 at the Westin... Read More
March 17, 2023
Clinical Study Results Involving Spryng, a PetVivo Product, Presented at Veterinary Orthopedic Society Annual Conference in Big Sky, Montana
MINNEAPOLIS, MN, US, March 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals announced that Erik Kleemam DVM, MPH, of Ethos Veterinary Health presented at the Veterinary Orthopedic Society (“VOS”) annual conference on the completion... Read More
March 10, 2023
PetVivo to Exhibit and Dr. Erik Kleeman of Ethos Veterinary Health to Present Canine Study Results at the Veterinary Orthopedic Society Annual Conference
MINNEAPOLIS, MN, US, March 10, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals announced today it will be exhibiting at the Veterinary Orthopedic Society (“VOS”) annual conference to be held March 11th to Marth 18th, 2023 at the... Read More
February 13, 2023
Petvivo Holdings to Exhibit at the Western Veterinary Conference In Las Vegas, Nevada
MINNEAPOLIS, Feb. 13, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the Western Veterinary Conference to be held February 19th to February 22nd, 2023 at the Mandalay Bay Convention Center in Las Vegas, Nevada. PetVivo intends to... Read More
February 9, 2023
PetVivo Reports Third Quarter of Fiscal 2023 Financial Results
Conference call begins at 4:00 p.m. Central time today EDINA, MN , Feb. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW) , an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the third quarter of fiscal 2023. The Company began commercialization of its lead product Spryng™ with OsteoCushion ™... Read More
February 2, 2023
Petvivo Holdings To Announce Results For The Third Quarter Ended December 31, 2022
MINNEAPOLIS, MN, US, Feb. 02, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Thursday, February 9, 2023 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day. Attendees of... Read More
January 30, 2023
Petvivo Holdings To Exhibit At The Minnesota Veterinary Medical Association Annual Meeting In Minneapolis, Minnesota
MINNEAPOLIS, Jan. 30, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the 2023 Minnesota Veterinary Medical Association Annual Meeting from February 2nd to February 4th, 2023 at the Hyatt Regency in Minneapolis,... Read More
January 26, 2023
PetVivo To Participate In The Lytham Partners Investor Select Conference
MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced that the Company will be participating in the Lytham Partners Investor Select Conference taking place virtually on January 31, 2023. John Lai, Chief Executive Officer... Read More
January 23, 2023
Petvivo to Exhibit at 44th Lake Tahoe Equine Conference In Incline Village, Nevada
MINNEAPOLIS, Jan. 23, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the 2023 Lake Tahoe Equine Conference from January 23rd to January 27th, 2023 at the Hyatt Lake Tahoe in Incline Village, Nevada. "The Lake... Read More
January 17, 2023
Petvivo To Exhibit At The 2023 Ocala Equine Conference In Ocala, Florida
MINNEAPOLIS, Jan. 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the 2023 FAEP Ocala Equine Conference from January 21 st to January 22 nd , 2023 at the World Equestrian Center in Ocala, FL. “We are looking... Read More
January 12, 2023
Petvivo Announces Plan For New Manufacturing Facility
MINNEAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it has entered into a lease agreement for approximately 14,000 sq. ft. of production and warehouse space located in Edina, Minnesota. This new facility will include... Read More
January 9, 2023
Petvivo to Exhibit at Veterinary Meeting and Expo Conference in Orlando, Florida
MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the Veterinary Meeting & Expo Conference from January 14th to January 18th, 2023 at the Orange County Convention Center in Orlando, FL. The... Read More
December 28, 2022
PetVivo Holdings Announces Application for Dual Listing on Upstream
MINNEAPOLIS, MN, Dec. 28, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) (the "Company" or “PetVivo”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, today announced that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs... Read More
Compass Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB